Lip leishmaniasis: Clinical characteristics of 621 patients

Yeşilova, Yavuz; Aksoy, Mustafa; Sürücü, Hacer Altun; Uluat, Ahmet; Ardic, Nurittin; Yeşilova, Abdullah

dc.contributor.author	Yeşilova, Yavuz
dc.contributor.author	Aksoy, Mustafa
dc.contributor.author	Sürücü, Hacer Altun
dc.contributor.author	Uluat, Ahmet
dc.contributor.author	Ardic, Nurittin
dc.contributor.author	Yeşilova, Abdullah
dc.date.accessioned	2019-06-13T08:20:13Z
dc.date.available	2019-06-13T08:20:13Z
dc.date.issued	2015
dc.identifier.other	DOI: 10.4103/2229-5151.170849
dc.identifier.uri	http://hdl.handle.net/11513/240
dc.description.abstract	Old world leishmaniasis is seen in a wide geographical area including Turkey, as well. The causative agent is generally Leishmaniasis tropica, and the agent is rarely identified to be leishmaniasis major in such patients.[1] Depending on the leishmaniasis type and the person’s immune system, it may be in one of the cutaneous, mucocutaneous leishmaniasis (ML), or visceral leishmaniasis (VL) forms.[2] Mucosal involvement is rarely seen with old world leishmaniasis.[3] ML disease is an important endemic disease and public health problem in undeveloped countries, since it has a significant rate of morbidity and mortality	en_US
dc.language.iso	en	en_US
dc.publisher	International Journal of Critical Illness & Injury Science	en_US
dc.title	Lip leishmaniasis: Clinical characteristics of 621 patients	en_US
dc.type	Article	en_US